Kim Maree Newberry

Mrs. Kim Maree Newberry


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Scientific and Technical Review
Verified
Journal Article
Closed access
KNKim Maree Newberry
Kim Maree Newberry
ACA. Colling
A. Colling
The World Organisation for Animal Health Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 1.1.1. summarises the most relevant governance and managerial aspects of veterinary testing laboratories, and Chapter 1.1.5. introduces quality management. Both chapters are based on the International Organization for Standardization/International Electrotechnical Commission standard, ISO/IEC 17025:2005 ‘General requirements for the competence of testing and calibration laboratories’. This paper provides an update of standards and regulatory bodies relevant for accreditation of quality management systems (QMS), with a focus on ISO/IEC 17025:2017 for testing and calibration laboratories. Important issues and considerations that a laboratory should address in the design and maintenance of its QMS are highlighted and examples provided, in particular aspects of test validation and verification, including measurement uncertainty (MU). A QMS aims to address all aspects of the laboratory operation, including staff, organisational structure, processes, and procedures. Accreditation of a diagnostic laboratory requires three notable components: (a) independent or third-party assessment; (b) suitably validated tests performed by proficient laboratory operators in an adequately equipped laboratory; and (c) ongoing internal and external quality control. Together, these components ensure a test outcome is the result of a standardised process and structured peer review, and demonstrate both competency and ability to produce technically valid diagnostic results that will meet the needs of customers – veterinarians, animal owners, regulators, organisations and industry – as well as the needs of decision-makers involved in animal health and surveillance programmes. En el capítulo 1.1.1 del Manual de las Pruebas de Diagnóstico y de las Vacunas para los Animales Terrestres de la Organización Mundial de Sanidad Animal (OIE) se resumen los aspectos más importantes de la dirección y la gestión de laboratorios de análisis veterinarios, mientras que en el capítulo 1.1.5 se aborda el tema de la gestión de la calidad. Ambos capítulos están basados en la norma ISO/IEC 17025:2005, “Requisitos generales para la competencia de los laboratorios de ensayo y de calibración” de la Organización Internacional de Normalización y la Comisión Electrotécnica Internacional. Los autores ofrecen información actualizada sobre las normas aplicables y los organismos de reglamentación competentes por lo que respecta a la certificación de sistemas de gestión de la calidad, partiendo básicamente de las disposiciones de la norma ISO/IEC 17025:2017 que se aplican a los laboratorios de ensayo y de calibración. También destacan las cuestiones y consideraciones importantes que un laboratorio debe tener en cuenta para concebir y mantener su sistema de gestión de la calidad, en particular los aspectos relativos a la validación y verificación de pruebas, incluida la incertidumbre de medición, y ofrecen ejemplos al respecto. Un sistema de gestión de la calidad tiene por objetivo cubrir todos los aspectos del funcionamiento de un laboratorio, lo que comprende su personal, su estructura organizativa y sus procesos y protocolos. La acreditación de un laboratorio de diagnóstico consta de tres componentes fundamentales: a) una evaluación por parte de un tercero independiente; b) la realización de pruebas debidamente validadas, a cargo de técnicos de laboratorio competentes, en un laboratorio convenientemente equipado; y c) controles continuos de la calidad, tanto internos como externos. La suma de estos componentes garantiza que los resultados de un ensayo sean fruto de un proceso normalizado y de una revisión por homólogos estructurada y demuestra que el laboratorio posee tanto la competencia como la capacidad necesarias para obtener resultados de diagnóstico técnicamente válidos, que respondan a las necesidades tanto de los clientes (veterinarios, propietarios de animales, organismos de reglamentación, organizaciones y entidades industriales) como de las instancias decisorias que intervienen en los programas de sanidad animal y vigilancia zoosanitaria. Le chapitre 1.1.1 du Manuel des tests de diagnostic et des vaccins pour les animaux terrestres de l’Organisation mondiale pour la santé animale donne une vue d’ensemble des principaux aspects de la gouvernance et de la gestion d’un laboratoire de diagnostic vétérinaire tandis que le chapitre 1.1.5 introduit aux principes de la gestion de la qualité dans les laboratoires. Les deux chapitres reposent sur la norme de l’Organisation internationale de normalisation/Commission électrotechnique internationale ISO/IEC 17025:2005, « Exigences générales concernant la compétence des laboratoires d’étalonnages et d’essais ». Les auteurs font le point sur l’état actuel des normes et des organismes de réglementation pertinents en matière d’accréditation des systèmes de gestion de la qualité , en mettant l’accent sur la norme ISO/IEC 17025:2017 qui est plus précisément axée sur les laboratoires d’essais et d’étalonnage. Les auteurs mettent en avant un certain nombre de questions et de considérations importantes qu’un laboratoire devrait prendre en compte lors de la conception et de la mise en œuvre continue de son système de gestion de la qualité et les illustrent d’exemples relatifs à des aspects particuliers de la validation et du contrôle des performances d’un test, notamment l’incertitude des mesures. Un système de gestion de la qualité...

21 November 2024 in Viruses
Verified
Journal Article
Open access
PDF file
ARAntonio Di Rubbo
Antonio Di Rubbo
KAKalpana Agnihotri
Kalpana Agnihotri
TBTimothy Bowden
Timothy Bowden
MGMichelle Giles
Michelle Giles
KNKim Maree Newberry
Kim Maree Newberry
JWJohn White
John White
A newly formatted enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to bluetongue virus (BTV) was developed and validated for bovine and ovine sera and plasma. Validation of the new sandwich ELISA (sELISA) was achieved with 949 negative bovine and ovine sera from BTV endemic and non-endemic areas of Australia and 752 BTV positive (field and experimental) sera verified by VNT and/or PCR. The test diagnostic sensitivity (DSe) and diagnostic specificity (DSp) were 99.70% and 99.20%, respectively, for bovine sera, and 97.80% and 99.50%, respectively, for ovine sera. Comparable diagnostic performances were noted for the sELISA compared to four competition ELISAs. While the sensitivity of the sELISA remained unaffected by BTV-15 positive sera, the cELISAs were not as sensitive. BTV-15 is endemic to Australia, and early warning depends on sensitive diagnoses of all serotypes: endemic or incurring. The sELISA failed to discriminate against epizootic hemorrhagic disease virus (EHDV) antibodies, the most serologically related orbivirus to BTV. The ACDP cELISA and the IDEXX kit showed cross-reactivity with some EHDV serotypes, with the least cross-reactive being the VMRD and the IDVet kits. Cross-reactivities, however, were also detected in sera raised experimentally from 10 isolates of the 21 known non-BTV orbiviruses. In this case, the sELISA was the least affected, followed equally by the VMRD and IDVet kits, and the IDEXX kit and the ACDP cELISA were the least discriminatory. In addition to exclusivity assessment of the ELISAs, an inclusivity assessment was made for all ELISAs using well characterized reference sera positive for antibodies to all serotypes BTV-1 to BTV-24.

18 November 2025 in Viruses
Verified
Journal Article
Open access
PDF file
MSMark Sistrom
Mark Sistrom
MNMatthew Neave
Matthew Neave
AJAncy Joseph
Ancy Joseph
KNKim Maree Newberry
Kim Maree Newberry
HAHannah Andrews
Hannah Andrews
RWRichard Weir
Richard Weir
Northern Australia has long been a hotbed of arboviral discovery, and collections of viral isolates from Northern Australia represent an invaluable resource for both our knowledge of viral diversity and for disease preparedness and treatment. While discovery of novel viruses via classical virology methods is on the decline, next generation sequencing offers the possibility to speed up viral discovery, albeit at the expense of the collection of valuable life history data. By sequencing unknown isolates from historical viral collections, we may leverage both the rich data collected through classical virology and the power of identification using contemporary sequencing technologies. In the present study, we sequenced 76 historical viral isolates held at the Berrimah Veterinary Laboratory in Darwin, northern Australia, for which serological typing had yielded ambiguous results. We determined that 43 of these isolates belong to the genera Hapavirus, Orbivirus, and Orthobunyavirus. Several of these isolates are putatively novel genotypes or potential taxa, which has significant potential implications for human and animal health. This study demonstrates the utility of historical collections for viral discovery and characterisation and how considerable past efforts to isolate and characterise viruses can be enhanced using next generation sequencing approaches.